navdx logo white

The first and only clinically validated circulating TTMV® DNA blood test that aids in the detection of HPV-driven cancer.

A highly accurate, reliable blood test.

NavDx is the first and only clinically validated circulating tumor-tissue–modified HPV (TTMV®) DNA blood test that aids in the detection of HPV-driven cancer.

 

NavDx uses proprietary technology to quantify fragments of circulating TTMV HPV DNA, a unique HPV-driven cancer biomarker that cancer cells shed into the blood. This highly accurate blood test reliably uncovers the presence of HPV+ head and neck cancer across the care continuum.¹˒²˒³

doctor with patient physicians

This innovative and accessible blood test for HPV+ cancer helps inform clinical decisions, enabling physicians to intervene earlier, which may result in improved outcomes.¹˒³

Get Started with NavDx


nav dx bottom